PSMA-Directed CAR T Cells Combined with Low-Dose Docetaxel Treatment Induce Tumor Regression in a Prostate Cancer Xenograft Model
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: Molecular Therapy Oncolytics 18.2020, September, S. 226-235
- Event
-
Veröffentlichung
- (where)
-
Furtwangen
- (who)
-
Hochschule Furtwangen
- (when)
-
2020
- Creator
-
Alzuʾbi, Jamal
Dettmer-Monaco, Viviane
Kühle, Johannes
Thorausch, Niko
Seidl, Maximilian
Taromi, Sanaz
Schamel, Wolfgang
Zeiser, Robert
Abken, Hinrich
Cathomen, Anton
Wolf, Philipp
- DOI
-
10.1016/j.omto.2020.06.014
- URN
-
urn:nbn:de:bsz:fn1-opus4-75799
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:32 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Alzuʾbi, Jamal
- Dettmer-Monaco, Viviane
- Kühle, Johannes
- Thorausch, Niko
- Seidl, Maximilian
- Taromi, Sanaz
- Schamel, Wolfgang
- Zeiser, Robert
- Abken, Hinrich
- Cathomen, Anton
- Wolf, Philipp
- Hochschule Furtwangen
Time of origin
- 2020
Other Objects (12)
Inhibition of the mouse double minute 2 protein promotes antileukemia immunity in human acute myeloid leukemia cells
PSMA-directed CAR T cells combined with low-dose docetaxel treatment induce tumor regression in a prostate cancer xenograft model
Regulation of human early B lymphopoiesis
Advances in understanding the pathogenesis of graft‐versus‐host disease
Establishing a zinc finger nuclease platform for targeted genome editing in human cell lines, primary keratinocyte stem cells and cardiomyocytes in vivo
Entwicklung von gentechnologischen Strategien zur Überwindung der Bluthirnschranke am Modell des Morbus Gaucher Typ 2
NLRP3 inflammasome activation in cancer: a double-edged sword
Immunomodulatory therapies for the treatment of graft-versus-host disease
Immune checkpoint inhibitor induced neurocognitive deficits in patients
Intestinal microbiota influence immune tolerance post allogeneic hematopoietic cell transplantation and intestinal GVHD
The role of purine metabolites as DAMPs in acute graft-versus-host disease
Die Rolle von extrazellulärem ATP bei der Entstehung der akuten Graft-©versus-©Host Erkrankung
Inhibition of the mouse double minute 2 protein promotes antileukemia immunity in human acute myeloid leukemia cells
PSMA-directed CAR T cells combined with low-dose docetaxel treatment induce tumor regression in a prostate cancer xenograft model
Regulation of human early B lymphopoiesis
Advances in understanding the pathogenesis of graft‐versus‐host disease
Establishing a zinc finger nuclease platform for targeted genome editing in human cell lines, primary keratinocyte stem cells and cardiomyocytes in vivo
Entwicklung von gentechnologischen Strategien zur Überwindung der Bluthirnschranke am Modell des Morbus Gaucher Typ 2
NLRP3 inflammasome activation in cancer: a double-edged sword
Immunomodulatory therapies for the treatment of graft-versus-host disease
Immune checkpoint inhibitor induced neurocognitive deficits in patients
Intestinal microbiota influence immune tolerance post allogeneic hematopoietic cell transplantation and intestinal GVHD
The role of purine metabolites as DAMPs in acute graft-versus-host disease
Die Rolle von extrazellulärem ATP bei der Entstehung der akuten Graft-©versus-©Host Erkrankung
Inhibition of the mouse double minute 2 protein promotes antileukemia immunity in human acute myeloid leukemia cells
PSMA-directed CAR T cells combined with low-dose docetaxel treatment induce tumor regression in a prostate cancer xenograft model
Regulation of human early B lymphopoiesis
Advances in understanding the pathogenesis of graft‐versus‐host disease
Establishing a zinc finger nuclease platform for targeted genome editing in human cell lines, primary keratinocyte stem cells and cardiomyocytes in vivo
Entwicklung von gentechnologischen Strategien zur Überwindung der Bluthirnschranke am Modell des Morbus Gaucher Typ 2
NLRP3 inflammasome activation in cancer: a double-edged sword
Immunomodulatory therapies for the treatment of graft-versus-host disease
Immune checkpoint inhibitor induced neurocognitive deficits in patients
Intestinal microbiota influence immune tolerance post allogeneic hematopoietic cell transplantation and intestinal GVHD
The role of purine metabolites as DAMPs in acute graft-versus-host disease